Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT01245803

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01245803
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01245803. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2011-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
Acronym
AVATAR
Condition
Acute Coronary Syndrome
Condition
Angioplasty
Intervention (Drug)
additional rosuvastatin loading
Intervention (Drug)
placebo control
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct01245803
Content hash
b6afe02a1f038faad766d4ccec8c449b5ebf889b7f627e39142f4df225b9b1ca